Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor

We propose a method to analyze platelet adhesion and aggregation computationally, taking into account the distinct properties of two plasma proteins, von Willebrand factor (vWF) and fibrinogen (Fbg). In this method, the hydrodynamic interactions between platelet particles under simple shear flow were simulated using Stokesian dynamics based on the additivity of velocities. The binding force between particles mediated by vWF and Fbg was modeled using the Voigt model. Two Voigt models with different properties were introduced to consider the distinct behaviors of vWF and Fbg. Our results qualitatively agreed with the general observation of a previous in-vitro experiment, thus demonstrating that the significant development of thrombus formation in height requires not only vWF, but also Fbg. This agreement of simulation and experimental results qualitatively validates our model and suggests that consideration of the distinct roles of vWF and Fbg is essential to investigate the physiological and pathophysiological mechanisms of thrombus formation using a computational approach.

[1]  W. Siess,et al.  Glycoprotein Ibα inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques , 2007, Thrombosis and Haemostasis.

[2]  Z. Ruggeri Platelet interactions with vessel wall components during thrombogenesis. , 2006, Blood cells, molecules & diseases.

[3]  Shigeo Wada,et al.  Computer Simulation of Formation and Collapse of Primary Thrombus due to Platelet Aggregation Using Particle Method , 2006 .

[4]  Zaverio M. Ruggeri,et al.  Platelets in atherothrombosis , 2002, Nature Medicine.

[5]  Z. Ruggeri von Willebrand factor and fibrinogen. , 1993, Current opinion in cell biology.

[6]  Z. Ruggeri Von Willebrand factor: Looking back and looking forward , 2007, Thrombosis and Haemostasis.

[7]  Brian Savage,et al.  Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor , 1996, Cell.

[8]  Satoh,et al.  Brownian Dynamics Simulations of Ferromagnetic Colloidal Dispersions in a Simple Shear Flow. , 1998, Journal of colloid and interface science.

[9]  Aaron L. Fogelson,et al.  Continuum models of platelet aggregation: formulation and mechanical properties , 1992 .

[10]  G. Shaw,et al.  The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time , 2007, Thrombosis and Haemostasis.

[11]  E. Topol,et al.  Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. , 1995, The New England journal of medicine.

[12]  A. Satoh Comparison of Approximations between Additivity of Velocities and Additivity of Forces for Stokesian Dynamics Methods , 2001 .

[13]  R. Marchant,et al.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.

[14]  Takami Yamaguchi,et al.  Formation and destruction of primary thrombi under the influence of blood flow and von Willebrand factor analyzed by a discrete element method. , 2003, Biorheology.

[15]  G. Shaw,et al.  Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis. , 2006, Thrombosis and haemostasis.

[16]  Aaron L. Fogelson,et al.  Computational Methods for Continuum Models of Platelet Aggregation , 1999 .

[17]  T. Ishikawa,et al.  Analysis of Destruction Process of the Primary Thrombus Under the Influence of the Blood Flow , 2007 .

[18]  S. Goto,et al.  Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. , 1998, The Journal of clinical investigation.

[19]  H. Weiss,et al.  Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. , 1971, The New England journal of medicine.

[20]  Masaaki Tamagawa,et al.  Predictions of Thrombus Formation Using Lattice Boltzmann Method , 2004 .

[21]  G. Karniadakis,et al.  Blood flow velocity effects and role of activation delay time on growth and form of platelet thrombi , 2006, Proceedings of the National Academy of Sciences.

[22]  H. Holmsen,et al.  Congenital disorders of platelet function. , 1990, Hematology/oncology clinics of North America.

[23]  G. Shaw,et al.  Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis , 2006, Thrombosis and Haemostasis.

[24]  Y. Ikeda,et al.  Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets (*) , 1995, The Journal of Biological Chemistry.

[25]  Louis J. Durlofsky,et al.  Dynamic simulation of hydrodynamically interacting particles , 1987, Journal of Fluid Mechanics.

[26]  R. Silver,et al.  Congenital disorders of platelet function. , 1999, Clinical obstetrics and gynecology.

[27]  M M Frojmovic,et al.  Human platelet size, shape, and related functions in health and disease. , 1982, Physiological reviews.

[28]  H. Weiss,et al.  Decreased adhesion of platelets to subendothelium in von Willebrand's disease. , 1974, The Journal of laboratory and clinical medicine.